155 related articles for article (PubMed ID: 9840913)
1. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
[No Abstract] [Full Text] [Related]
2. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
Leach M; Parsons RM; Reilly JT; Winfield DA
Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
[TBL] [Abstract][Full Text] [Related]
3. Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine.
Timuragaoglu A; Karadogan I; Undar L
Ann Hematol; 1999 Feb; 78(2):109-10. PubMed ID: 10089031
[No Abstract] [Full Text] [Related]
4. Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.
Savage DG; Cohen NS; Hesdorffer CS; Heitjan D; Oster MW; Garrett TJ; Bar M; del Prete S; March R; Lonberg M; Talbot S; Mears JG; Flamm M; Taub RN; Nichols G
Leuk Lymphoma; 2003 Mar; 44(3):477-81. PubMed ID: 12688318
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
Hamblin TJ; Orchard JA; Myint H; Oscier DG
J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
[No Abstract] [Full Text] [Related]
6. [Drug-induced hemolytic anemia].
Wautier JL; Rouger P
Transfus Clin Biol; 2001 Aug; 8(4):377-80. PubMed ID: 11642029
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine in the treatment of lymphoproliferative malignancies.
Feldman EJ; Keating MJ
Cancer Invest; 1993; 11(3):314-8. PubMed ID: 8485654
[No Abstract] [Full Text] [Related]
8. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
[No Abstract] [Full Text] [Related]
9. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.
Byrd JC; Hertler AA; Weiss RB; Freiman J; Kweder SL; Diehl LF
Ann Oncol; 1995 Mar; 6(3):300-1. PubMed ID: 7612497
[No Abstract] [Full Text] [Related]
10. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
[No Abstract] [Full Text] [Related]
11. Evans syndrome complicating fludarabine treatment for advanced B-CLL.
Shvidel L; Shtarlid M; Klepfish A; Sigler E; Berrebi A
Br J Haematol; 1997 Dec; 99(3):706. PubMed ID: 9401088
[No Abstract] [Full Text] [Related]
12. Fludarabine phosphate--looking forward.
Cheson BD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
[No Abstract] [Full Text] [Related]
13. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
[TBL] [Abstract][Full Text] [Related]
14. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
Pawelski S
Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
[No Abstract] [Full Text] [Related]
16. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Antich Rojas J; Balaguer H; Cladera A
Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
[No Abstract] [Full Text] [Related]
17. [Ulcers in a patient with chronic lymphocytic leukemia].
León-Mateos A; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2007 May; 98(4):279-80. PubMed ID: 17506962
[No Abstract] [Full Text] [Related]
18. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
19. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
[No Abstract] [Full Text] [Related]
20. Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
Anaissie EJ; Kontoyiannis DP; O'Brien S; Kantarjian H; Robertson L; Lerner S; Keating MJ
Ann Intern Med; 1998 Oct; 129(7):559-66. PubMed ID: 9758577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
